Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

被引：0
|
作者：
Danni Li
Fangying Huang
Yingchun Zhao
Peter W. Villata
Timothy J. Griffin
Lin Zhang
Ling Li
Fang Yu
机构：
[1] University of Minnesota,Department of Laboratory Medicine and Pathology
[2] University of Minnesota,Masonic Cancer Center
[3] University of Minnesota,Department of Biochemistry, Molecular Biology, and Biophysics
[4] University of Minnesota,Department of Biostatistics
[5] University of Minnesota,Department of Experimental and Clinical Pharmacology
[6] University of Minnesota,School of Nursing
来源：
Clinical Proteomics | 2018年 / 15卷
关键词：
Alzheimer’s disease; Plasma lipoproteins; Targeted proteomics; Complement C3; Very low-density lipoprotein (VLDL); Intermediate density lipoprotein (IDL); Low density lipoprotein (LDL); High-density lipoprotein (HDL); Biomarker; Diagnosis; Selected reaction monitoring (SRM);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease: A Proof-of-Concept Six Years Prospective Study
    Ferreri, Florinda
    Guerra, Andrea
    Vollero, Luca
    Ponzo, David
    Maeaetta, Sara
    Koenoenen, Mervi
    Vecchio, Fabrizio
    Pasqualetti, Patrizio
    Miraglia, Francesca
    Simonelli, Ilaria
    Corbetta, Maurizio
    Rossini, Paolo Maria
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [42] Blockgraph Proof-of-Concept
    Cordova, David A. M.
    Velloso, Pedro B.
    Guerre, Alexandre
    Nguyen, Thi-Mai-Trang
    Pujolle, Guy
    Alagha, Khaldoun
    Dua, Guillaume
    PROCEEDINGS OF THE 2021 SIGCOMM 2021 POSTER AND DEMO SESSIONS, SIGCOMM 2021 DEMOS AND POSTERS, 2024, : 82 - 84
  • [43] KLOTHO AS A BIOMARKER OF SUBCLINICAL CARDIOVASCULAR DISEASE IN CHRONIC KIDNEY DISEASE: A PROOF-OF-CONCEPT STUDY
    Ferri, C. M.
    Donate-Correa, J. J.
    Martin-Nunez, E.
    Perez-Delgado, N.
    Gonzalez-Luis, A.
    Mora-Fernandez, C.
    Navarro-Gonzalez, J. F.
    ATHEROSCLEROSIS, 2021, 331 : E237 - E237
  • [44] KLOTHO AS A BIOMARKER OF SUBCLINICAL CARDIOVASCULAR DISEASE IN CHRONIC KIDNEY DISEASE: A PROOF-OF-CONCEPT STUDY
    Ferri, Carla
    Donate-Correa, Javier
    Martin-Nunez, Ernesto
    Perez-Delgado, Nayra
    Gonzalez-Luis, Ainhoa
    Mora-Fernandez, Carmen
    Navarro-Gonzalez, Juan F.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [45] The paperless Labeling initiative: A proof-of-concept study
    Ruchalski, C
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (7-8) : 1178 - 1182
  • [46] Sleep parameters assessed by actigraphy in Fabry's disease patients: a proof-of-concept
    da Silva Vallim, Julia Ribeiro
    do Amaral, Fernanda Gaspar
    D'Almeida, Vania
    SLEEP MEDICINE, 2020, 69 : 213 - 216
  • [47] Spesolimab for hidradenitis suppurativa: A proof-of-concept study
    Alavi, Afsaneh
    Prens, Errol
    Kimball, Alexa B.
    Krueger, James G.
    Mukhopadhyay, Sutirtha
    Wang, Hui
    Ivanoff, Nathalie B.
    Daly, Ana C. Hernandez
    Zouboulis, Christos C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB89 - AB89
  • [48] Proton Grid Therapy: A Proof-of-Concept Study
    Henry, Thomas
    Ureba, Ana
    Valdman, Alexander
    Siegbahn, Albert
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2017, 16 (06) : 749 - 757
  • [49] Proof-of-concept study testing bevantolol (SOM3355) as treatment of chorea in Huntington's disease
    Gamez, J.
    Calopa, M.
    Munoz, E.
    Ferre, A.
    Huertas, O.
    McAllister, K.
    Reig, N.
    Scart-Gres, C.
    Insa, R.
    Kulisevsky, J.
    MOVEMENT DISORDERS, 2021, 36 : S101 - S101
  • [50] Recruitment rate, feasibility and safety of power training in individuals with Parkinson's disease: a proof-of-concept study
    Lima, Lidiane O.
    Rodrigues-de-Paula, Fatima
    BRAZILIAN JOURNAL OF PHYSICAL THERAPY, 2013, 17 (01) : 49 - 56
12345